Norman Eansor
Président chez MARKER THERAPEUTICS, INC.
Fortune : 16 124 $ au 30/04/2024
Profil
Norman David Eansor is currently the Independent Chairman at Marker Therapeutics, Inc., the Director at B-MoGen Biotechnologies, Inc., and the President at Cyvek, Inc. Previously, he held positions such as President-Bioproducts Business Unit at Cambrex Corp., Vice President-Pharmaceutical Operations at R.P.
Scherer Corp., President-Protein Sciences Segment at Bio-Techne Corp., President-Bioscience Division at Thermo Fisher Scientific, Inc., Vice President-Operations at Cardinal Health Corp., and Senior Vice President-Development & MD at Novus Biologicals LLC.
Mr. Eansor obtained an undergraduate degree from the University of Western Ontario and an MBA from the University of Windsor.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/03/2024 | 3 694 ( 0,04% ) | 16 124 $ | 30/04/2024 |
Postes actifs de Norman Eansor
| Sociétés | Poste | Début |
|---|---|---|
| MARKER THERAPEUTICS, INC. | Président | 24/05/2022 |
B-MoGen Biotechnologies, Inc.
 B-MoGen Biotechnologies, Inc. BiotechnologyHealth Technology B-MoGen Biotechnologies, Inc. provides gene editing solutions for antibody validation, human disease research, gene transfer, and mitochondrial DNA editing. It offers custom vector generation services that include multi-gene expression vectors that are delivered via the proven sleeping beauty transposon system; and custom gene targeting vectors. The company was founded by David A. Largaespada and Branden S. Moriarity in 2015 and is headquartered in Minneapolis, MN. | Directeur/Membre du Conseil | - |
CyVek, Inc.
 CyVek, Inc. BiotechnologyHealth Technology CyVek, Inc. engages in the development of a novel, platform technology for measuring analytes in biological samples. It is a biotechnology company dedicated to the advancement of healthcare by empowering researchers and clinicians with a disruptive technology for performing multi-analyte immunoassays. The firm is a versatile platform that can be quickly and easily configured for diverse applications such as rapid diagnostic tests, multi-sample multi-analyte tests, or routine ELISA-like tests, for use in both research and clinical settings. The company offers an breadth of applications, from life science research to drug discovery, personalized medicine, diagnostics, and point-of-care testing. CyVek was founded by Per J. Hellsund, Rajiv Pandey and Marty Andrew Putnam in 2010 and is headquartered in Wallingford, CT. | President | - |
Anciens postes connus de Norman Eansor
| Sociétés | Poste | Fin |
|---|---|---|
| BIO-TECHNE CORPORATION | Corporate Officer/Principal | 03/01/2022 |
Novus Biologicals LLC
 Novus Biologicals LLC Pharmaceuticals: MajorHealth Technology Novus Biologicals LLC develops and markets antibodies for scientific researchers in government, university, and biotech labs worldwide. It provides primary antibodies, secondary antibodies, antibody packs, lysates, peptides and proteins, antibody pairs, kits, RNAi, slides, isotype controls, support products, and various research reagents. Novus products are used in various research areas, including apoptosis, autophagy, cancer, DNA repair, epigenetics, epitope tags, GPCR, hypoxia, lipid and metabolism, loading controls, neuroscience, stem cell markers, cellular markers, immunology, and protein turnover. The company was founded by Karen M. Padgett in 1996 and is headquartered Littleton, CO. | Corporate Officer/Principal | 01/01/2015 |
| THERMO FISHER SCIENTIFIC | Corporate Officer/Principal | 01/01/2013 |
| CAMBREX CORPORATION | Corporate Officer/Principal | 01/01/2005 |
Cardinal Health Corp.
 Cardinal Health Corp. Medical DistributorsDistribution Services Part of Cardinal Health, Inc., this company manufactures and distributes hospital equipment. The company is based in Memphis, TN. | Directeur des opérations | 01/01/2000 |
Formation de Norman Eansor
| University of Western Ontario | Undergraduate Degree |
| University of Windsor | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| BIO-TECHNE CORPORATION | Health Technology |
| MARKER THERAPEUTICS, INC. | Health Technology |
| THERMO FISHER SCIENTIFIC | Health Technology |
| Entreprise privées | 6 |
|---|---|
Cambrex Corp.
 Cambrex Corp. Pharmaceuticals: GenericHealth Technology Cambrex Corp. engages in the provision of products, services, and technologies to accelerate and improve the development and commercialization of new and generic therapeutics. It supplies to innovator and generic pharmaceutical companies. Its products include generic and branded APIs, controlled substances, chiral compounds, high potency APIs, and advanced intermediates. The company was founded by Arthur Mendolia and Cyril C. Baldwin Jr. in 1981 and is headquartered in East Rutherford, NJ. | Health Technology |
R.P. Scherer Corp.
 R.P. Scherer Corp. Pharmaceuticals: MajorHealth Technology R.P. Scherer Corp. Develops and manufactures oral drug delivery systems. The company offers different types of medical services and products. It has approximately 4 medical faculties in United States. The company is located in Troy, MI | Health Technology |
CyVek, Inc.
CyVek, Inc. BiotechnologyHealth Technology CyVek, Inc. engages in the development of a novel, platform technology for measuring analytes in biological samples. It is a biotechnology company dedicated to the advancement of healthcare by empowering researchers and clinicians with a disruptive technology for performing multi-analyte immunoassays. The firm is a versatile platform that can be quickly and easily configured for diverse applications such as rapid diagnostic tests, multi-sample multi-analyte tests, or routine ELISA-like tests, for use in both research and clinical settings. The company offers an breadth of applications, from life science research to drug discovery, personalized medicine, diagnostics, and point-of-care testing. CyVek was founded by Per J. Hellsund, Rajiv Pandey and Marty Andrew Putnam in 2010 and is headquartered in Wallingford, CT. | Health Technology |
Novus Biologicals LLC
Novus Biologicals LLC Pharmaceuticals: MajorHealth Technology Novus Biologicals LLC develops and markets antibodies for scientific researchers in government, university, and biotech labs worldwide. It provides primary antibodies, secondary antibodies, antibody packs, lysates, peptides and proteins, antibody pairs, kits, RNAi, slides, isotype controls, support products, and various research reagents. Novus products are used in various research areas, including apoptosis, autophagy, cancer, DNA repair, epigenetics, epitope tags, GPCR, hypoxia, lipid and metabolism, loading controls, neuroscience, stem cell markers, cellular markers, immunology, and protein turnover. The company was founded by Karen M. Padgett in 1996 and is headquartered Littleton, CO. | Health Technology |
Cardinal Health Corp.
Cardinal Health Corp. Medical DistributorsDistribution Services Part of Cardinal Health, Inc., this company manufactures and distributes hospital equipment. The company is based in Memphis, TN. | Distribution Services |
B-MoGen Biotechnologies, Inc.
B-MoGen Biotechnologies, Inc. BiotechnologyHealth Technology B-MoGen Biotechnologies, Inc. provides gene editing solutions for antibody validation, human disease research, gene transfer, and mitochondrial DNA editing. It offers custom vector generation services that include multi-gene expression vectors that are delivered via the proven sleeping beauty transposon system; and custom gene targeting vectors. The company was founded by David A. Largaespada and Branden S. Moriarity in 2015 and is headquartered in Minneapolis, MN. | Health Technology |